Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
| Image |  |
|---|---|
| Description | scientific article published on 17 June 2015 |
| Author/s |
author: Tadao Akizawa Eiji Nakatani |
| Publication date | June 17, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |